About
A CRO specializing in biosafety testing, founded in the Shanghai Free Trade Zone in 2022. It performs safety testing and ICH Q5A(R2) viral clearance validation for antibodies and ADCs, cell and gene therapies (CGT) (viral vectors, CAR-T, stem cells), recombinant proteins, vaccines and nucleic acid drugs, and supplies more than 20 CelerQ residual host cell DNA qPCR kits developed in-house.
Products
Product Lines
Testing Services
- Antibody drug (mAb · ADC · RDC) testing
- Cell and gene therapy (CGT) testing (viral vectors · oncolytic viruses · stem cells · CAR-T/TCR-T · CAR-NK · TIL)
- Recombinant protein · vaccine · nucleic acid drug (mRNA · siRNA) testing
- Virus removal validation (ICH Q5A(R2)) · molecular biology · microbiology · virology · cell biology · immunology platforms
CelerQ residual DNA quantitation kits (qPCR)
- HEK293/T · CHO · Vero · NS0 · MDCK · SF9 · Hi5 · E.coli · Pichia · Hansenula
- E1A · E1B · SV40 LTA · Plasmid · Porcine
- Residual DNA fragment distribution analysis kits · residual RNA kits
CGT Safety · Sample Preparation
- CelerQ CAR/TCR Copy Number Kit
- CelerQ RCL Detection Kit
- Host Residual DNA Sample Pre-treatment Kit · DNA Cleaner Kit